Name: RPRX Income Statement - Royalty Pharma Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

RPRX - Royalty Pharma PLC

USD | NASDAQ | Healthcare

RPRX Income Statement - Royalty Pharma Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q3 FY 19	Q2 FY 19
Revenues
Revenues	630.6	622.0	609.3	578.7	568.2	593.6	564.7	537.3	568.0	596.1	536.3	538.2	684.0	565.7	573.5	536.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Revenues
Revenues	2,440.5	2,378.2	2,263.6	2,354.6	2,237.2	2,289.5	2,122.4	1,814.3	1,794.9
Cost of Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-
Operating Expenses
Research & Development	441.3	452.0	2.0	52.0	177.1	200.1	26.3	83.0	392.6
Selling General & Administrative	-	-	-	-
Operating Income
Operating Income	1,588.4	1,559.5	1,292.4	1,492.2	307.1	1,430.7	1,595.4	2,623.2	1,364.4
Non-Operating
Interest Income	28.5	33.6	47.3	72.3	78.3	-	-	-	-
Interest Expense	336.1	307.7	225.5	187.2	188.0
Tax & Net
Income Tax Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Income From Continuing Ops	1,358.0	1,324.2	1,330.8	1,700.1
Per Share
EPS Basic	1.89	1.79	1.92	2.54	0.10	1.49	1.32	-	-
EPS Diluted	1.48	1.78	1.91	2.53	0.10
Supplementary Data
EBITDA	-	1,563.4	1,292.4	1,492.2	-	-	-	-	-
EBIT	1,588.4	1,559.5	1,292.4	1,492.2	307.1

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	39.8	50.5	50.5	300.5	50.5	0.5	0.5	0.5	0.5	0.5	50.5	0.5	0.5	50.5	25.5	0.6	100.5	103.8	90.5	3.1	2.6	-	5.1	5.8	7.6	22.7	21.5
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	159.5	164.3	118.7	179.8	110.7	67.6	56.7	54.7	57.7	59.2	57.2	47.6	85.7	73.2	50.7	51.8	51.5
Depreciation & Amortization	1.2	-	-	-	0.0	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	67.5	233.6	182.1	368.9	34.1	232.1	(170.4)	267.6	641.8	(16.8)	384.9	289.4	205.0	1,048.4	381.3

Operating Income
Operating Income	563.0	388.4	427.2	209.8	534.2	361.5	735.1	269.6	(73.8)	612.9	151.4	248.8	479.0	(482.7)	192.2	377.8	219.7	153.4	303.1	744.9	229.3	-	510.6	409.3	361.4	532.5	327.9

Non-Operating
Interest Income	6.2	7.1	6.9	8.3	11.3	9.0	17.5	13.4	7.4	6.5	23.4	25.7	16.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	93.7	94.2	79.6	68.7	65.3	65.8	66.5	49.0	44.2	47.3	46.0	46.9	47.0	47.0	47.0	47.0	47.1	47.0
Income From Equity Investments	21.8	4.0	15.9	2.7	6.4	31.7	10.4	1.7	(14.1)	0.3	(5.2)	(0.8)	34.6	(6.9)	(3.3)	0.7
Other Non-Operating Income	(94.8)	(33.5)	17.1	(119.2)	(99.7)	(27.2)	71.3	(75.3)	69.5	104.7	(29.4)	102.5	30.1	(127.4)	28.2	113.8	(91.6)
Pre-Tax Income	468.3	354.9	444.2	90.6	434.4	334.4	806.4	194.4	(4.3)	717.6	122.1	351.3	509.1	(610.0)	220.4	491.6

Tax & Net
Income Tax Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	0.0	0.0	0.0	0.0	0.0
Net Income From Continuing Ops	468.3	354.9	444.2	90.6	434.4	334.4	806.4	194.4	(4.3)	717.6	122.1	351.3	509.1	(610.0)	220.4	491.6	128.1
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	468.3	354.9	444.2	90.6	434.4	334.4	806.4	194.4	(4.3)	717.6	122.1	351.3	509.1	(610.0)	220.4	491.6	128.1
Net Income Attributable To Parent	294.7	213.2	288.2	30.2	239.3	208.2	544.0	102.0	4.8	494.3	72.1	227.6	340.8	(456.1)	142.7	304.5
Less: Minority Interest	173.6	141.7	156.0	60.5	195.1	126.1	262.4	92.4	(9.1)	223.2	50.0	123.7	168.3	(153.9)	77.8	187.1	76.3
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	294.7	213.2	288.2	30.2	239.3	208.2	544.0	102.0	4.8	494.3	72.1	227.6	340.8	(456.1)	142.7

Per Share
EPS Basic	0.67	-	0.67	0.07	0.55	-	1.22	0.23	0.01	-	0.16	0.51	0.76	-	0.32	0.70	0.12	-	0.24	1.08	0.18	-	0.79	0.09	-	-	-
EPS Diluted	0.67	-	0.67	0.07	0.55	-	1.21	0.23	0.01	-	0.16	0.50	0.76	-	0.32	0.70	0.12	-
Shares Basic	436.8	-	431.9	423.5	435.5	-	447.6	451.0	448.6	-	448.4	450.4	445.6	-	439.3	436.3	434.0	-
Shares Diluted	556.8	-	559.6	562.3	578.1	-	592.7	596.9	597.5	-	601.1	605.9	607.3	-	607.2	607.2	607.2	-

Supplementary Data
EBITDA	564.2	-	-	-	534.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	563.0	388.4	427.2	209.8	534.2	361.5	735.1	269.6	(73.8)	612.9	151.4	248.8	479.0	(482.7)	192.2	377.8	219.7	153.4	303.1